SomnoMed Limited (SOM.AX)
AUD 0.43
(0.0%)
AUD 0.43
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 55.13 Million AUD | 20.45% |
| 2023 | 45.76 Million AUD | 16.9% |
| 2022 | 39.15 Million AUD | 15.48% |
| 2021 | 33.9 Million AUD | 12.96% |
| 2020 | 30.01 Million AUD | -13.18% |
| 2019 | 34.57 Million AUD | 8.53% |
| 2018 | 31.85 Million AUD | 10.57% |
| 2017 | 28.8 Million AUD | 13.68% |
| 2016 | 25.34 Million AUD | 30.02% |
| 2015 | 19.49 Million AUD | 15.96% |
| 2014 | 16.8 Million AUD | 37.03% |
| 2013 | 12.26 Million AUD | 17.51% |
| 2012 | 10.43 Million AUD | 24.98% |
| 2011 | 8.35 Million AUD | 31.3% |
| 2010 | 6.36 Million AUD | 47.38% |
| 2009 | 4.31 Million AUD | 120.62% |
| 2008 | 1.95 Million AUD | 95.23% |
| 2007 | 1 Million AUD | 25.19% |
| 2006 | 800.58 Thousand AUD | 2760.34% |
| 2005 | 27.98 Thousand AUD | 220.25% |
| 2004 | -23.27 Thousand AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 FY | 49.35 Million AUD | 7.84% |
| 2024 Q4 | 24.19 Million AUD | 0.0% |
| 2024 Q2 | 24.63 Million AUD | 0.0% |
| 2023 Q4 | 23.47 Million AUD | 0.0% |
| 2023 Q2 | 22.28 Million AUD | 0.0% |
| 2023 FY | 45.76 Million AUD | 16.9% |
| 2022 Q2 | 19.03 Million AUD | 0.0% |
| 2022 Q4 | 20.75 Million AUD | 0.0% |
| 2022 FY | 39.15 Million AUD | 15.48% |
| 2021 FY | 33.9 Million AUD | 12.96% |
| 2021 Q2 | 16.25 Million AUD | 0.0% |
| 2021 Q4 | 17.64 Million AUD | 0.0% |
| 2020 Q2 | 18.1 Million AUD | 0.0% |
| 2020 Q4 | 11.9 Million AUD | 0.0% |
| 2020 FY | 30.01 Million AUD | -13.18% |
| 2019 Q4 | 17.55 Million AUD | 0.0% |
| 2019 FY | 34.57 Million AUD | 8.53% |
| 2019 Q2 | 17.01 Million AUD | 0.0% |
| 2018 FY | 31.85 Million AUD | 10.57% |
| 2018 Q2 | 14.73 Million AUD | 0.0% |
| 2018 Q4 | 17.11 Million AUD | 0.0% |
| 2017 Q2 | 13.7 Million AUD | 0.0% |
| 2017 FY | 28.8 Million AUD | 13.68% |
| 2017 Q4 | 15.1 Million AUD | 0.0% |
| 2016 Q2 | 12.27 Million AUD | 0.0% |
| 2016 Q4 | 13.07 Million AUD | 0.0% |
| 2016 FY | 25.34 Million AUD | 30.02% |
| 2015 FY | 19.49 Million AUD | 15.96% |
| 2015 Q4 | 9.97 Million AUD | 0.0% |
| 2015 Q2 | 9.51 Million AUD | 0.0% |
| 2014 FY | 16.8 Million AUD | 37.03% |
| 2014 Q4 | 8.68 Million AUD | 0.0% |
| 2014 Q2 | 8.12 Million AUD | 0.0% |
| 2013 Q2 | 5.96 Million AUD | 0.0% |
| 2013 FY | 12.26 Million AUD | 17.51% |
| 2013 Q4 | 6.3 Million AUD | 0.0% |
| 2012 Q4 | 2.6 Million AUD | 0.0% |
| 2012 Q1 | 2.08 Million AUD | 0.0% |
| 2012 Q3 | 2.6 Million AUD | 0.0% |
| 2012 FY | 10.43 Million AUD | 24.98% |
| 2012 Q2 | 2.6 Million AUD | 24.98% |
| 2011 FY | 8.35 Million AUD | 31.3% |
| 2011 Q1 | 1.56 Million AUD | 0.0% |
| 2011 Q2 | 2.08 Million AUD | 33.17% |
| 2011 Q3 | 2.08 Million AUD | 0.0% |
| 2011 Q4 | 2.08 Million AUD | 0.0% |
| 2010 Q4 | 1.56 Million AUD | 0.0% |
| 2010 Q1 | 1.07 Million AUD | 0.0% |
| 2010 Q2 | 1.56 Million AUD | 45.3% |
| 2010 Q3 | 1.56 Million AUD | 0.0% |
| 2010 FY | 6.36 Million AUD | 47.38% |
| 2009 Q1 | 489.17 Thousand AUD | 0.0% |
| 2009 Q3 | 1.07 Million AUD | 0.0% |
| 2009 Q4 | 1.07 Million AUD | 0.0% |
| 2009 FY | 4.31 Million AUD | 120.62% |
| 2009 Q2 | 1.07 Million AUD | 120.62% |
| 2008 Q4 | 489.17 Thousand AUD | 0.0% |
| 2008 Q3 | 489.17 Thousand AUD | 0.0% |
| 2008 Q2 | 489.17 Thousand AUD | 95.23% |
| 2008 Q1 | 250.55 Thousand AUD | 0.0% |
| 2008 FY | 1.95 Million AUD | 95.23% |
| 2007 Q1 | 200.14 Thousand AUD | 0.0% |
| 2007 FY | 1 Million AUD | 25.19% |
| 2007 Q3 | 250.55 Thousand AUD | 0.0% |
| 2007 Q4 | 250.55 Thousand AUD | 0.0% |
| 2007 Q2 | 250.55 Thousand AUD | 25.19% |
| 2006 Q3 | 200.14 Thousand AUD | 0.0% |
| 2006 Q2 | 200.14 Thousand AUD | 2760.44% |
| 2006 Q4 | 200.14 Thousand AUD | 0.0% |
| 2006 FY | 800.58 Thousand AUD | 2760.34% |
| 2006 Q1 | 6997.00 AUD | 0.0% |
| 2005 Q4 | 6997.00 AUD | 0.0% |
| 2005 FY | 27.98 Thousand AUD | 220.25% |
| 2005 Q3 | 6997.00 AUD | 0.0% |
| 2005 Q1 | -5818.25 AUD | 0.0% |
| 2005 Q2 | 6997.00 AUD | 220.26% |
| 2004 Q2 | -5818.25 AUD | 0.0% |
| 2004 Q4 | -5818.25 AUD | 0.0% |
| 2004 FY | -23.27 Thousand AUD | 0.0% |
| 2004 Q3 | -5818.25 AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| 4DMedical Limited | 3.51 Million AUD | -1467.324% |
| Adherium Limited | -640.83 Thousand AUD | 8703.033% |
| Aroa Biosurgery Limited | 53.98 Million AUD | -2.116% |
| Atomo Diagnostics Limited | 1.43 Million AUD | -3737.339% |
| Anteris Technologies Ltd | 2.51 Million AUD | -2090.198% |
| Control Bionics Limited | 3.67 Million AUD | -1401.078% |
| CardieX Limited | 10.1 Million AUD | -445.435% |
| Compumedics Limited | 26.06 Million AUD | -111.49% |
| Cochlear Limited | 1.69 Billion AUD | 96.75% |
| CleanSpace Holdings Limited | 11.35 Million AUD | -385.339% |
| Cyclopharm Limited | 4.49 Million AUD | -1125.867% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | -391.401% |
| Nova Eye Medical Limited | 20.19 Million AUD | -173.022% |
| HeraMED Limited | -504.09 Thousand AUD | 11036.678% |
| Imricor Medical Systems, Inc. | -1.99 Million AUD | 2866.394% |
| ImpediMed Limited | 9 Million AUD | -512.229% |
| InhaleRx Limited | 1.2 Million AUD | -4478.832% |
| LBT Innovations Limited | -2.91 Million AUD | 1989.998% |
| Micro-X Limited | 5.73 Million AUD | -860.977% |
| Neurotech International Limited | -5867.00 AUD | 939783.757% |
| OncoSil Medical Limited | 55.63 Thousand AUD | -98999.881% |
| PolyNovo Limited | 36.08 Million AUD | -52.782% |
| Respiri Limited | 456.91 Thousand AUD | -11966.001% |
| Universal Biosensors, Inc. | 4.28 Million AUD | -1186.629% |
| Uscom Limited | 3.11 Million AUD | -1669.469% |
| Visioneering Technologies, Inc. | -271.11 Thousand AUD | 20434.929% |